Results 171 to 180 of about 5,163 (181)

Activity of ceftaroline against pathogens associated with community-acquired pneumonia collected as part of the AWARE surveillance program, 2015–2016

Diagnostic Microbiology and Infectious Disease, 2019
Greg Stone, In-Gyu Bae
exaly  

Ceftaroline fosamil

Reactions Weekly, 2015
openaire   +2 more sources

Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010)

International Journal of Antimicrobial Agents, 2013
Helio S Sader, Ronald N Jones, David J Farrell   +2 more
exaly  

Ceftaroline Fosamil

Infectious Diseases in Clinical Practice, 2012
openaire   +1 more source

Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

Drugs, 2016
exaly  

Ceftaroline Fosamil

Reactions Weekly
openaire   +2 more sources

Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis

Journal of Cystic Fibrosis, 2018
Gregory Priebe, Emily E Barsky
exaly  

Ceftaroline and ceftaroline-avibactam

2017
openaire   +1 more source

Ceftaroline: a critique

2014
openaire   +1 more source

A series of pharmacokinetic studies of ceftaroline fosamil in select populations: Normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis

Journal of Clinical Pharmacology, 2014
exaly